- Home
- BDTX vs OCCI Comparison
BDTX vs OCCI Comparison
Compare BDTX & OCCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BDTX | OCCI |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.8M | 120.2M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | BDTX | OCCI |
|---|---|---|
| Price | $2.14 | $2.89 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $10.40 | N/A |
| AVG Volume (30 Days) | ★ 564.6K | 549.4K |
| Earning Date | 01-01-0001 | 12-11-2023 |
| Dividend Yield | N/A | ★ 24.32% |
| EPS Growth | ★ 32.45 | N/A |
| EPS | ★ 0.65 | N/A |
| Revenue | ★ N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.19 |
| P/E Ratio | $3.28 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.20 | $2.79 |
| 52 Week High | $4.94 | $7.17 |
Technical Indicators
Market Signals| Indicator | BDTX | OCCI |
|---|---|---|
| Relative Strength Index (RSI) | 40.78 | 28.78 |
| Support Level | $1.93 | $2.83 |
| Resistance Level | $2.67 | $4.97 |
| Average True Range (ATR) | 0.14 | 0.15 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 26.76 | 17.11 |
Price Performance
Historical ComparisonAbout BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About OCCI OFS Credit Company Inc.
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation through investment in collateralized loan obligation (CLO) equity and debt securities. The company invests in floating rate credit instruments and other structured credit investments, including collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.